Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.

Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States

Open access

Abstract

INTRODUCTION: Staphylococcus aureus is one of the most common pathogens in health care facilities and in the community, and can cause invasive infections, sepsis, and death. Despite progress in preventing methicillin-resistant S. aureus (MRSA) infections in health care settings, assessment of the problem in both health care and community settings is needed. Further, the epidemiology of methicillin-susceptible S. aureus (MSSA) infections is not well described at the national level. METHODS: Data from the Emerging Infections Program (EIP) MRSA population surveillance (2005-2016) and from the Premier and Cerner Electronic Health Record databases (2012-2017) were analyzed to describe trends in incidence of hospital-onset and community-onset MRSA and MSSA bloodstream infections and to estimate the overall incidence of S. aureus bloodstream infections in the United States and associated in-hospital mortality. RESULTS: In 2017, an estimated 119,247 S. aureus bloodstream infections with 19,832 associated deaths occurred. During 2005-2012 rates of hospital-onset MRSA bloodstream infection decreased by 17.1% annually, but the decline slowed during 2013-2016. Community-onset MRSA declined less markedly (6.9% annually during 2005-2016), mostly related to declines in health care-associated infections. Hospital-onset MSSA has not significantly changed (p = 0.11), and community-onset MSSA infections have slightly increased (3.9% per year, p<0.0001) from 2012 to 2017. CONCLUSIONS AND IMPLICATIONS FOR PUBLIC HEALTH PRACTICE: Despite reductions in incidence of MRSA bloodstream infections since 2005, S. aureus infections account for significant morbidity and mortality in the United States. To reduce the incidence of these infections further, health care facilities should take steps to fully implement CDC recommendations for prevention of device- and procedure-associated infections and for interruption of transmission. New and novel prevention strategies are also needed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15585/mmwr.mm6809e1

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Adjusted* methicillin-resistant Staphylococcus aureus bloodstream infection rates from population based surveillance — six U.S. Emerging Infections Program sites,† 2005–2016 * Adjusted for year and distribution of age, sex, and race among overall and dialysis population. Community-onset infections comprise health care–associated community-onset and community-associated infections † California (three counties), Connecticut (statewide), Georgia (eight counties), Minnesota (one county), New York (one county), and Tennessee (one county).
FIGURE 1 Adjusted* methicillin-resistant Staphylococcus aureus bloodstream infection rates from population based surveillance — six U.S. Emerging Infections Program sites,† 2005–2016 * Adjusted for year and distribution of age, sex, and race among overall and dialysis population. Community-onset infections comprise health care–associated community-onset and community-associated infections † California (three counties), Connecticut (statewide), Georgia (eight counties), Minnesota (one county), New York (one county), and Tennessee (one county).CC BY · PubMed Central
FIGURE 2 Adjusted* hospital-onset and community-onset rates of Staphylococcus aureus bloodstream infections — Premier and Cerner Hospitals, United States, 2012–2017 Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillin-susceptible Staphylococcus aureus. * Modeled relative to observed rates in 2012. Model adjusts for discharge month and year and hospital region, teaching status, bed size, and distributions of patient age, sex and race, in addition to accounting for repeated measures and clustering by facility.
FIGURE 2 Adjusted* hospital-onset and community-onset rates of Staphylococcus aureus bloodstream infections — Premier and Cerner Hospitals, United States, 2012–2017 Abbreviations: MRSA = methicillin-resistant Staphylococcus aureus; MSSA = methicillin-susceptible Staphylococcus aureus. * Modeled relative to observed rates in 2012. Model adjusts for discharge month and year and hospital region, teaching status, bed size, and distributions of patient age, sex and race, in addition to accounting for repeated measures and clustering by facility.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 701

Metadata

Authors
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., Ray, S. M., Emerging Infections Program MRSA author group, Ham, D., Capers, C., Ewing, H., Coffin, N., McDonald, L. C., Jernigan, J., & Cardo, D.
Affiliations
University of Rochester Medicine (US)
Corresponding author
Kourtis, Athena P.
Venue
MMWR. Morbidity and Mortality Weekly Report
Published
2019-03-08
Volume
68
Issue
9
Pages
214-219
ISSN
  • 0149-2195 (ISSN-L)
  • 1545-861X
OpenAlex
W2919520691
Cited by
701
References
27
Citations by year
2026: 50 · 2025: 96 · 2024: 98 · 2023: 103 · 2022: 127 · 2021: 100 · 2020: 90 · 2019: 36
FWCI
67.67
Type
journal article
Language
en
Open access
Locations
  • MMWR Morbidity and Mortality Weekly Report (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Infectious Diseases › Infection Control in Healthcare
Keywords
methicillin-resistant Staphylococcus aureus, methicillin-susceptible Staphylococcus aureus, bloodstream infection, community-onset infection, hospital-onset infection, incidence trends, in-hospital mortality, nosocomial infections, infection control, antimicrobial resistance, United States
MeSH terms
Cross Infection, Female, Humans, Male, Methicillin, Population Surveillance, Staphylococcal Infections, Staphylococcus aureus, United States, Incidence, Databases, Factual, Bacteremia, Hospital Mortality, Methicillin-Resistant Staphylococcus aureus, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States. https://app.cochat.ai/papers/10.15585/mmwr.mm6809e1
The paper
Kourtis, A. P., Hatfield, K., Baggs, J., Mu, Y., See, I., Epson, E., Nadle, J., Kainer, M. A., Dumyati, G., Petit, S., Ray, S. M., Emerging Infections Program MRSA author group, Ham, D., Capers, C., Ewing, H., Coffin, N., McDonald, L. C., Jernigan, J., & Cardo, D. (2019). Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections — United States. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm6809e1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.